This paper presents an in vivo test for assessment of regenerate axial stiffness after the distraction phase of lengthening therapy. The test result supplements radiography in evaluating bone healing and assists in determining when the regenerate stiffness is sufficient for removal of the external fixator. The test is non-invasive and does not require fixator removal. The theoretical basis for the method is that an externally applied load is shared between the fixator and the regenerating bone. The amount of load carried by the regenerate depends on its axial stiffness, which increases with advanced mineralization. By measuring the force in the fixator while applying a known external load to the limb, the load-share ratio between fixator and limb can be assessed. A load-share ratio of 100% indicates that the entire load is carried by the fixator. The ratio decreases as the regenerate structure gradually stiffens. In a clinical trial of 22 individuals with tibia1 lengthening, the fixator was removed when the load-share ratio dropped below 100/0. None of the patients experienced fracture after removal of the fixator.
The purpose of this investigation was to compare the tissue response during mono-and bifocal limb lengthening. The study includes four patients undergoing leg lengthening. All patients started out bifocally with a total diurnal distraction of 1.75 mm, but proceeded monofocally with a rate of 1 mm a day when the distal distraction was terminated due to contractures or pain. The tissue response was monitored by registration of axial force in the distraction rods. The force increased linearly during bifocal lengthening, but culminated or decreased in the period of monofocal lengthening. Average tissue stiffness, defined as the immediate force increase due to each 0.25 mm distraction increment, was significantly higher in the bifocal lengthening phase. The force decay between each distraction was significantly lower during bifocal lengthening, thus indicating decreased tissue accommodation. Details in the force registrations indicated that the soft tissue, not the regenerate, was the main contributor to the tensile force. Conclusively, the tissues at the two osteotomy sites do not lengthen independently. Bifocal lengthening exposes the entire soft tissue to large loads, resulting in increased tissue stiffness and reduced ability to adapt to the increased length. Accordingly, bifocal leg lengthening requires special attention to soft tissue adaptation.
The present study investigates the effect of distraction frequency on the development of tensile force in the tissues during lengthening. Two patients with bilateral Ilizarov leg lengthening underwent distraction with high frequency in one leg and low frequency in the other. The clinical situation represented a unique model for investigating the effect of distraction frequency, as each individual served as its own control. Both patients had double level lengthening. Distraction frequency at the proximal lengthening zone was 0.25 mm x 4 in the first leg and 1/1440 mm once every minute in the other. Total diurnal distraction at the proximal metaphysis was 1 mm in both legs. In addition, a distal metaphyseal distraction of 0.25 mm x 3 daily was performed on each leg. The tissue's mechanical response was monitored by measuring the tensile force at the proximal osteotomy. Both patients experienced a significant lower level of force during the high frequency lengthening. The lower level of force was concluded to be due to improved soft tissue adaptation, rather than reduced bone regeneration. Accordingly, high distraction frequency was considered favouiabk to low frequency, and is recommended in large lengthenings where high force levels are expected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.